Net position, by region
One dot per nation. The bar marks each region’s mean. Filled dots are net gains; hollow dots are net losses.
Readiness against outcome
Each nation’s readiness to take the gain against its net position. Nations below the zero line lose more than they capture.
Mean net position by region
Loss exposure in this scenario: standing outside the surveillance and manufacturing network.
All 197 nations
Capture is gain exposure times readiness. Loss is loss exposure times what adaptability does not cover. The binding capability is the weakest of those the scenario requires: raising it raises the capture rate most.
| Binding capability | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | Singapore | Indo-Pacific | Gainer | +66.5 | 67.3 | 0.8 | 77 | 83 | Information Environment & Strategic Communication 14.3 · Established |
| 2 | Netherlands | Europe | Gainer | +64.9 | 65.9 | 1.0 | 75 | 79 | Information Environment & Strategic Communication 13.7 · Established |
| 3 | Sweden | Europe | Gainer | +62.4 | 63.3 | 1.0 | 76 | 81 | Information Environment & Strategic Communication 14 · Established |
| 4 | Germany | Europe | Gainer | +61.3 | 62.1 | 0.8 | 81 | 84 | Population Health 15.7 · Advanced |
| 5 | France | Europe | Gainer | +61.2 | 62.0 | 0.8 | 83 | 85 | Population Health 16.3 · Advanced |
| 6 | South Korea | Indo-Pacific | Gainer | +61.0 | 61.8 | 0.9 | 80 | 83 | Information Environment & Strategic Communication 15.7 · Advanced |
| 7 | Japan | Indo-Pacific | Gainer | +60.1 | 61.0 | 0.8 | 82 | 84 | Information Environment & Strategic Communication 15.7 · Advanced |
| 8 | United Kingdom | Europe | Gainer | +58.5 | 59.3 | 0.7 | 83 | 86 | Population Health 16 · Advanced |
| 9 | Denmark | Europe | Gainer | +57.5 | 58.6 | 1.1 | 70 | 78 | Information Environment & Strategic Communication 12 · Established |
| 10 | Switzerland | Europe | Gainer | +57.4 | 58.5 | 1.1 | 73 | 77 | Information Environment & Strategic Communication 12.7 · Established |
| 11 | Belgium | Europe | Gainer | +56.0 | 57.4 | 1.4 | 65 | 71 | Information Environment & Strategic Communication 11 · Transitional |
| 12 | Finland | Europe | Gainer | +55.5 | 56.6 | 1.0 | 71 | 79 | Information Environment & Strategic Communication 12.7 · Established |
| 13 | Taiwan | Indo-Pacific | Gainer | +55.4 | 56.6 | 1.2 | 70 | 77 | Biotechnology & Health Technologies 13.2 · Established |
| 14 | Canada | North America | Gainer | +52.7 | 54.9 | 2.2 | 74 | 78 | Information Environment & Strategic Communication 13.7 · Established |
| 15 | Australia | Indo-Pacific | Gainer | +51.7 | 52.7 | 1.0 | 76 | 81 | Information Environment & Strategic Communication 14.3 · Established |
| 16 | Spain | Europe | Gainer | +51.2 | 52.5 | 1.3 | 71 | 75 | Biotechnology & Health Technologies 13.6 · Established |
| 17 | Norway | Europe | Gainer | +50.9 | 52.0 | 1.0 | 69 | 79 | Biotechnology & Health Technologies 12 · Established |
| 18 | United States | North America | Gainer | +49.3 | 51.0 | 1.6 | 78 | 84 | Population Health 14 · Established |
| 19 | Italy | Europe | Gainer | +47.4 | 49.0 | 1.5 | 68 | 70 | Information Environment & Strategic Communication 13 · Established |
| 20 | Ireland | Europe | Gainer | +46.4 | 48.0 | 1.6 | 62 | 69 | Biotechnology & Health Technologies 11 · Transitional |
| 21 | Austria | Europe | Gainer | +45.2 | 46.7 | 1.5 | 62 | 71 | Information Environment & Strategic Communication 10.3 · Transitional |
| 22 | Israel | Gulf and Middle East | Gainer | +43.7 | 46.3 | 2.6 | 72 | 74 | Information Environment & Strategic Communication 13.7 · Established |
| 23 | Czechia | Europe | Gainer | +43.1 | 44.9 | 1.8 | 56 | 65 | Biotechnology & Health Technologies 9.8 · Transitional |
| 24 | New Zealand | Indo-Pacific | Gainer | +41.9 | 43.1 | 1.3 | 62 | 75 | Biotechnology & Health Technologies 10.2 · Transitional |
| 25 | Poland | Europe | Gainer | +41.7 | 43.4 | 1.7 | 60 | 66 | Biotechnology & Health Technologies 11.2 · Transitional |
| 26 | Hungary | Europe | Gainer | +41.0 | 43.0 | 2.0 | 53 | 59 | Information Environment & Strategic Communication 9.3 · Transitional |
| 27 | Portugal | Europe | Gainer | +40.8 | 42.4 | 1.6 | 56 | 68 | Biotechnology & Health Technologies 9.6 · Transitional |
| 28 | Estonia | Europe | Gainer | +40.4 | 41.8 | 1.4 | 51 | 72 | Biotechnology & Health Technologies 7.4 · Foundational |
| 29 | Lithuania | Europe | Gainer | +38.5 | 40.3 | 1.8 | 50 | 64 | Biotechnology & Health Technologies 8 · Foundational |
| 30 | Malaysia | Indo-Pacific | Gainer | +37.8 | 39.7 | 1.9 | 53 | 61 | Biotechnology & Health Technologies 9.4 · Transitional |
| 31 | Slovenia | Europe | Gainer | +37.2 | 39.2 | 2.0 | 50 | 60 | Information Environment & Strategic Communication 8 · Foundational |
| 32 | Luxembourg | Europe | Gainer | +36.1 | 37.7 | 1.7 | 44 | 67 | Biotechnology & Health Technologies 5 · Nascent |
| 33 | China | China | Gainer | +34.8 | 39.6 | 4.8 | 67 | 76 | Population Health 11.7 · Transitional |
| 34 | Greece | Europe | Gainer | +34.6 | 36.8 | 2.2 | 46 | 56 | Biotechnology & Health Technologies 7.4 · Foundational |
| 35 | Iceland | Europe | Gainer | +34.4 | 36.2 | 1.8 | 46 | 64 | Biotechnology & Health Technologies 6 · Foundational |
| 36 | Thailand | Indo-Pacific | Gainer | +34.1 | 36.2 | 2.1 | 51 | 59 | Biotechnology & Health Technologies 9 · Transitional |
| 37 | Brazil | Latin America and Caribbean | Gainer | +32.1 | 35.8 | 3.7 | 59 | 63 | Population Health 11.3 · Transitional |
| 38 | Malta | Europe | Gainer | +31.9 | 34.1 | 2.1 | 38 | 58 | Biotechnology & Health Technologies 4.4 · Nascent |
| 39 | Latvia | Europe | Gainer | +30.8 | 32.8 | 2.0 | 41 | 60 | Biotechnology & Health Technologies 5.6 · Nascent |
| 40 | Slovakia | Europe | Gainer | +30.5 | 32.7 | 2.1 | 44 | 57 | Biotechnology & Health Technologies 6.6 · Foundational |
| 41 | Türkiye | Gulf and Middle East | Gainer | +30.2 | 33.5 | 3.3 | 57 | 67 | Biotechnology & Health Technologies 10.4 · Transitional |
| 42 | Romania | Europe | Gainer | +30.0 | 32.2 | 2.2 | 47 | 55 | Biotechnology & Health Technologies 8.4 · Foundational |
| 43 | Bulgaria | Europe | Gainer | +29.5 | 32.0 | 2.5 | 40 | 50 | Biotechnology & Health Technologies 6.6 · Foundational |
| 45 | Mexico | Latin America and Caribbean | Gainer | +29.4 | 33.6 | 4.2 | 52 | 58 | Biotechnology & Health Technologies 9.8 · Transitional |
| 44 | United Arab Emirates | Gulf and Middle East | Gainer | +29.4 | 32.6 | 3.1 | 51 | 69 | Biotechnology & Health Technologies 8 · Foundational |
| 46 | Serbia | Europe | Gainer | +28.4 | 30.7 | 2.3 | 43 | 54 | Biotechnology & Health Technologies 6.8 · Foundational |
| 47 | Croatia | Europe | Gainer | +28.1 | 30.3 | 2.2 | 40 | 56 | Biotechnology & Health Technologies 5.6 · Nascent |
| 48 | Vietnam | Indo-Pacific | Gainer | +27.7 | 30.0 | 2.3 | 46 | 54 | Biotechnology & Health Technologies 8.2 · Foundational |
| 49 | Chile | Latin America and Caribbean | Gainer | +26.4 | 30.5 | 4.1 | 45 | 59 | Biotechnology & Health Technologies 6.6 · Foundational |
| 50 | Argentina | Latin America and Caribbean | Gainer | +24.8 | 29.5 | 4.7 | 47 | 53 | Information Environment & Strategic Communication 8 · Foundational |
| 52 | Cyprus | Europe | Gainer | +24.2 | 26.6 | 2.3 | 35 | 53 | Biotechnology & Health Technologies 3.8 · Nascent |
| 51 | South Africa | Africa | Gainer | +24.2 | 30.8 | 6.7 | 51 | 56 | Population Health 9.3 · Transitional |
| 53 | Saudi Arabia | Gulf and Middle East | Gainer | +23.6 | 27.0 | 3.4 | 50 | 66 | Biotechnology & Health Technologies 8 · Foundational |
| 54 | Russia | Russia and Eurasia | Gainer | +22.9 | 32.9 | 10.0 | 56 | 67 | Population Health 10 · Transitional |
| 55 | Indonesia | Indo-Pacific | Gainer | +22.7 | 25.1 | 2.3 | 46 | 53 | Biotechnology & Health Technologies 8.6 · Foundational |
| 56 | Cuba | Latin America and Caribbean | Gainer | +21.9 | 26.5 | 4.6 | 44 | 54 | Research Talent & Knowledge Creation 7.3 · Foundational |
| 57 | Iran | Gulf and Middle East | Gainer | +21.6 | 26.4 | 4.7 | 49 | 53 | Biotechnology & Health Technologies 9.4 · Transitional |
| 58 | Uruguay | Latin America and Caribbean | Gainer | +21.4 | 26.0 | 4.6 | 38 | 54 | Biotechnology & Health Technologies 5 · Nascent |
| 59 | Monaco | Europe | Gainer | +20.5 | 23.0 | 2.6 | 25 | 49 | Biotechnology & Health Technologies 1.2 · Inception |
| 60 | Qatar | Gulf and Middle East | Gainer | +19.5 | 23.0 | 3.5 | 39 | 65 | Biotechnology & Health Technologies 4.4 · Nascent |
| 61 | India | South Asia | Gainer | +19.4 | 23.3 | 4.0 | 50 | 60 | Population Health 8.3 · Foundational |
| 62 | Colombia | Latin America and Caribbean | Gainer | +19.0 | 23.8 | 4.7 | 40 | 53 | Biotechnology & Health Technologies 6.2 · Foundational |
| 63 | Morocco | Africa | Gainer | +18.5 | 25.8 | 7.3 | 39 | 51 | Biotechnology & Health Technologies 6.4 · Foundational |
| 64 | Costa Rica | Latin America and Caribbean | Gainer | +18.3 | 23.0 | 4.7 | 35 | 53 | Biotechnology & Health Technologies 4.2 · Nascent |
| 65 | Tunisia | Africa | Gainer | +16.8 | 24.8 | 8.0 | 38 | 47 | Biotechnology & Health Technologies 6 · Foundational |
| 66 | Philippines | Indo-Pacific | Gainer | +16.6 | 19.1 | 2.5 | 37 | 49 | Biotechnology & Health Technologies 6 · Foundational |
| 67 | Peru | Latin America and Caribbean | Gainer | +15.9 | 21.1 | 5.2 | 36 | 48 | Biotechnology & Health Technologies 5.6 · Nascent |
| 68 | Montenegro | Europe | Gainer | +15.8 | 18.6 | 2.8 | 25 | 45 | Biotechnology & Health Technologies 2 · Inception |
| 69 | Ukraine | Russia and Eurasia | Gainer | +15.7 | 28.1 | 12.4 | 44 | 59 | Biotechnology & Health Technologies 7 · Foundational |
| 70 | North Macedonia | Europe | Gainer | +15.6 | 18.4 | 2.8 | 25 | 43 | Biotechnology & Health Technologies 2.4 · Inception |
| 71 | Jordan | Gulf and Middle East | Gainer | +15.1 | 20.4 | 5.3 | 32 | 48 | Biotechnology & Health Technologies 4.4 · Nascent |
| 72 | Andorra | Europe | Gainer | +14.1 | 16.9 | 2.7 | 20 | 45 | Biotechnology & Health Technologies 0.2 · Inception |
| 73 | San Marino | Europe | Gainer | +13.9 | 16.8 | 2.8 | 18 | 43 | Biotechnology & Health Technologies 0 · Inception |
| 74 | Oman | Gulf and Middle East | Gainer | +13.8 | 18.6 | 4.9 | 29 | 51 | Biotechnology & Health Technologies 2.8 · Inception |
| 75 | Mauritius | Africa | Gainer | +13.4 | 20.7 | 7.3 | 33 | 51 | Biotechnology & Health Technologies 3.8 · Nascent |
| 76 | Kuwait | Gulf and Middle East | Gainer | +13.3 | 18.3 | 5.1 | 29 | 50 | Biotechnology & Health Technologies 3 · Nascent |
| 77 | Egypt | Gulf and Middle East | Gainer | +12.7 | 17.6 | 5.0 | 44 | 50 | Biotechnology & Health Technologies 8.2 · Foundational |
| 79 | Mongolia | Indo-Pacific | Gainer | +12.5 | 15.5 | 3.0 | 23 | 40 | Biotechnology & Health Technologies 2.2 · Inception |
| 78 | Panama | Latin America and Caribbean | Gainer | +12.5 | 17.9 | 5.4 | 28 | 46 | Biotechnology & Health Technologies 3.2 · Nascent |
| 80 | Bahrain | Gulf and Middle East | Gainer | +12.4 | 17.5 | 5.1 | 26 | 49 | Biotechnology & Health Technologies 2 · Inception |
| 81 | Bosnia & Herzegovina | Europe | Gainer | +12.0 | 15.1 | 3.1 | 22 | 38 | Biotechnology & Health Technologies 2 · Inception |
| 84 | Lebanon | Gulf and Middle East | Gainer | +11.9 | 18.4 | 6.6 | 25 | 34 | Biotechnology & Health Technologies 3.6 · Nascent |
| 83 | Brunei | Indo-Pacific | Gainer | +11.9 | 14.7 | 2.8 | 20 | 44 | Biotechnology & Health Technologies 0.6 · Inception |
| 82 | Liechtenstein | Europe | Gainer | +11.9 | 14.6 | 2.6 | 25 | 48 | Biotechnology & Health Technologies 1.4 · Inception |
| 85 | North Korea | Indo-Pacific | Gainer | +10.9 | 14.3 | 3.4 | 21 | 32 | Research Talent & Knowledge Creation 3 · Nascent |
| 87 | Albania | Europe | Gainer | +10.8 | 13.7 | 2.9 | 20 | 43 | Biotechnology & Health Technologies 1.2 · Inception |
| 86 | Ecuador | Latin America and Caribbean | Gainer | +10.8 | 16.6 | 5.8 | 29 | 42 | Biotechnology & Health Technologies 3.8 · Nascent |
| 88 | Belarus | Russia and Eurasia | Mixed | +9.8 | 25.5 | 15.7 | 34 | 48 | Biotechnology & Health Technologies 5.2 · Nascent |
| 89 | Bangladesh | South Asia | Mixed | +9.3 | 15.4 | 6.1 | 33 | 39 | Biotechnology & Health Technologies 5.6 · Nascent |
| 90 | Algeria | Africa | Mixed | +9.1 | 17.6 | 8.5 | 31 | 43 | Biotechnology & Health Technologies 4.4 · Nascent |
| 91 | Trinidad & Tobago | Latin America and Caribbean | Mixed | +9.0 | 14.8 | 5.8 | 25 | 42 | Biotechnology & Health Technologies 2.2 · Inception |
| 92 | Jamaica | Latin America and Caribbean | Mixed | +8.8 | 14.8 | 5.9 | 24 | 41 | Biotechnology & Health Technologies 2.6 · Inception |
| 93 | Dominican Republic | Latin America and Caribbean | Mixed | +8.6 | 14.5 | 5.9 | 24 | 41 | Biotechnology & Health Technologies 2.4 · Inception |
| 95 | Kosovo | Europe | Mixed | +8.5 | 11.9 | 3.3 | 17 | 33 | Biotechnology & Health Technologies 1.2 · Inception |
| 94 | Sri Lanka | South Asia | Mixed | +8.5 | 13.9 | 5.4 | 31 | 46 | Biotechnology & Health Technologies 4.2 · Nascent |
| 96 | Fiji | Indo-Pacific | Mixed | +8.4 | 11.7 | 3.2 | 18 | 36 | Biotechnology & Health Technologies 1 · Inception |
| 98 | El Salvador | Latin America and Caribbean | Mixed | +7.8 | 14.0 | 6.2 | 22 | 39 | Biotechnology & Health Technologies 2 · Inception |
| 97 | Ghana | Africa | Mixed | +7.8 | 16.6 | 8.8 | 31 | 41 | Biotechnology & Health Technologies 4.8 · Nascent |
| 99 | Pakistan | South Asia | Mixed | +7.7 | 13.6 | 6.0 | 32 | 40 | Population Health 5.3 · Nascent |
| 100 | Venezuela | Latin America and Caribbean | Mixed | +7.6 | 14.7 | 7.1 | 22 | 29 | Biotechnology & Health Technologies 3.4 · Nascent |
| 101 | Paraguay | Latin America and Caribbean | Mixed | +6.5 | 12.7 | 6.2 | 21 | 39 | Biotechnology & Health Technologies 1.8 · Inception |
| 102 | Cambodia | Indo-Pacific | Mixed | +5.8 | 9.3 | 3.4 | 17 | 32 | Biotechnology & Health Technologies 1.4 · Inception |
| 105 | Maldives | South Asia | Mixed | +5.2 | 11.5 | 6.2 | 18 | 38 | Biotechnology & Health Technologies 1 · Inception |
| 104 | Senegal | Africa | Mixed | +5.2 | 14.2 | 9.0 | 29 | 40 | Biotechnology & Health Technologies 4.6 · Nascent |
| 103 | Nigeria | Africa | Mixed | +5.2 | 14.0 | 8.9 | 28 | 41 | Population Health 4.3 · Nascent |
| 106 | Seychelles | Africa | Mixed | +4.9 | 13.8 | 9.0 | 19 | 40 | Biotechnology & Health Technologies 0.8 · Inception |
| 107 | Kazakhstan | Russia and Eurasia | Mixed | +4.8 | 19.6 | 14.8 | 37 | 51 | Biotechnology & Health Technologies 5.8 · Nascent |
| 108 | Bahamas | Latin America and Caribbean | Mixed | +4.7 | 10.9 | 6.2 | 16 | 38 | Biotechnology & Health Technologies 0.2 · Inception |
| 109 | Georgia | Russia and Eurasia | Mixed | +4.5 | 19.6 | 15.1 | 30 | 50 | Biotechnology & Health Technologies 3.4 · Nascent |
| 111 | Barbados | Latin America and Caribbean | Mixed | +4.3 | 10.1 | 5.8 | 20 | 42 | Biotechnology & Health Technologies 0.8 · Inception |
| 110 | Botswana | Africa | Mixed | +4.3 | 13.2 | 8.9 | 21 | 41 | Biotechnology & Health Technologies 1.8 · Inception |
| 112 | Holy See | Europe | Mixed | +3.9 | 7.5 | 3.6 | 8 | 28 | Biotechnology & Health Technologies 0 · Inception |
| 113 | Laos | Indo-Pacific | Mixed | +3.8 | 7.5 | 3.7 | 13 | 26 | Biotechnology & Health Technologies 1 · Inception |
| 114 | Myanmar | Indo-Pacific | Mixed | +3.6 | 7.5 | 3.9 | 15 | 23 | Biotechnology & Health Technologies 2.2 · Inception |
| 116 | Palau | Indo-Pacific | Mixed | +3.3 | 7.1 | 3.8 | 10 | 24 | Biotechnology & Health Technologies 0 · Inception |
| 115 | Bolivia | Latin America and Caribbean | Mixed | +3.3 | 9.8 | 6.5 | 18 | 35 | Biotechnology & Health Technologies 1.2 · Inception |
| 117 | Namibia | Africa | Mixed | +3.2 | 12.5 | 9.3 | 21 | 38 | Biotechnology & Health Technologies 2 · Inception |
| 120 | Nicaragua | Latin America and Caribbean | Mixed | +3.1 | 10.0 | 6.9 | 17 | 31 | Biotechnology & Health Technologies 1.4 · Inception |
| 119 | Guatemala | Latin America and Caribbean | Mixed | +3.1 | 9.7 | 6.6 | 21 | 34 | Biotechnology & Health Technologies 2.2 · Inception |
| 118 | Kenya | Africa | Mixed | +3.1 | 11.6 | 8.5 | 32 | 43 | Biotechnology & Health Technologies 5.2 · Nascent |
| 121 | Honduras | Latin America and Caribbean | Mixed | +3.0 | 9.9 | 6.9 | 18 | 31 | Biotechnology & Health Technologies 1.8 · Inception |
| 122 | Rwanda | Africa | Mixed | +2.9 | 11.2 | 8.4 | 29 | 44 | Biotechnology & Health Technologies 4.2 · Nascent |
| 123 | Iraq | Gulf and Middle East | Mixed | +2.8 | 9.7 | 6.9 | 19 | 31 | Biotechnology & Health Technologies 2.2 · Inception |
| 124 | Tonga | Indo-Pacific | Mixed | +2.5 | 6.2 | 3.7 | 11 | 26 | Biotechnology & Health Technologies 0.2 · Inception |
| 126 | Marshall Islands | Indo-Pacific | Mixed | +2.1 | 6.0 | 3.9 | 8 | 22 | Biotechnology & Health Technologies 0 · Inception |
| 125 | Samoa | Indo-Pacific | Mixed | +2.1 | 5.8 | 3.6 | 12 | 27 | Biotechnology & Health Technologies 0.2 · Inception |
| 127 | Dominica | Latin America and Caribbean | Mixed | +2.0 | 9.0 | 7.0 | 13 | 30 | Biotechnology & Health Technologies 0.2 · Inception |
| 128 | Suriname | Latin America and Caribbean | Mixed | +1.9 | 9.0 | 7.1 | 14 | 29 | Biotechnology & Health Technologies 0.6 · Inception |
| 129 | Grenada | Latin America and Caribbean | Mixed | +1.7 | 8.7 | 6.9 | 14 | 31 | Biotechnology & Health Technologies 0.4 · Inception |
| 131 | Palestine | Gulf and Middle East | Mixed | +1.6 | 8.5 | 6.8 | 16 | 32 | Biotechnology & Health Technologies 1.4 · Inception |
| 130 | Nepal | South Asia | Mixed | +1.6 | 8.4 | 6.8 | 19 | 32 | Biotechnology & Health Technologies 2 · Inception |
| 132 | Nauru | Indo-Pacific | Mixed | +1.5 | 5.5 | 4.0 | 7 | 19 | Biotechnology & Health Technologies 0 · Inception |
| 133 | Tuvalu | Indo-Pacific | Mixed | +1.4 | 5.4 | 4.0 | 8 | 20 | Biotechnology & Health Technologies 0 · Inception |
| 134 | Antigua & Barbuda | Latin America and Caribbean | Mixed | +1.3 | 8.0 | 6.7 | 14 | 33 | Biotechnology & Health Technologies 0.2 · Inception |
| 135 | Armenia | Russia and Eurasia | Mixed | +1.2 | 18.0 | 16.8 | 26 | 44 | Biotechnology & Health Technologies 2.8 · Inception |
| 136 | Guyana | Latin America and Caribbean | Mixed | +1.1 | 8.1 | 6.9 | 15 | 31 | Biotechnology & Health Technologies 1 · Inception |
| 137 | Saint Vincent & Grenadines | Latin America and Caribbean | Mixed | +1.0 | 8.1 | 7.1 | 13 | 29 | Biotechnology & Health Technologies 0.4 · Inception |
| 139 | Kiribati | Indo-Pacific | Mixed | +0.9 | 4.9 | 4.0 | 8 | 20 | Biotechnology & Health Technologies 0 · Inception |
| 138 | Solomon Islands | Indo-Pacific | Mixed | +0.9 | 4.8 | 3.9 | 10 | 22 | Biotechnology & Health Technologies 0.2 · Inception |
| 140 | Bhutan | South Asia | Mixed | +0.8 | 7.5 | 6.7 | 14 | 33 | Biotechnology & Health Technologies 0.2 · Inception |
| 142 | Papua New Guinea | Indo-Pacific | Mixed | +0.7 | 4.6 | 4.0 | 12 | 20 | Biotechnology & Health Technologies 1.2 · Inception |
| 141 | Cabo Verde | Africa | Mixed | +0.7 | 10.2 | 9.5 | 16 | 37 | Biotechnology & Health Technologies 0.4 · Inception |
| 144 | Saint Kitts & Nevis | Latin America and Caribbean | Mixed | +0.6 | 7.6 | 7.1 | 13 | 29 | Biotechnology & Health Technologies 0.4 · Inception |
| 143 | Saint Lucia | Latin America and Caribbean | Mixed | +0.6 | 7.6 | 7.1 | 13 | 29 | Biotechnology & Health Technologies 0.4 · Inception |
| 145 | Vanuatu | Indo-Pacific | Mixed | +0.5 | 4.5 | 3.9 | 10 | 22 | Biotechnology & Health Technologies 0.2 · Inception |
| 146 | Timor-Leste | Indo-Pacific | Mixed | +0.4 | 4.3 | 3.9 | 9 | 22 | Biotechnology & Health Technologies 0 · Inception |
| 147 | Micronesia | Indo-Pacific | Mixed | +0.3 | 4.3 | 4.0 | 8 | 21 | Biotechnology & Health Technologies 0 · Inception |
| 148 | Belize | Latin America and Caribbean | Mixed | 0.0 | 7.0 | 7.0 | 13 | 30 | Biotechnology & Health Technologies 0.2 · Inception |
| 149 | Tanzania | Africa | Mixed | −0.4 | 9.5 | 9.9 | 24 | 34 | Biotechnology & Health Technologies 3.4 · Nascent |
| 150 | Moldova | Russia and Eurasia | Mixed | −0.8 | 15.5 | 16.3 | 27 | 46 | Biotechnology & Health Technologies 3 · Nascent |
| 151 | Gabon | Africa | Mixed | −0.9 | 10.2 | 11.0 | 15 | 26 | Biotechnology & Health Technologies 1.4 · Inception |
| 153 | Zambia | Africa | Mixed | −1.1 | 9.5 | 10.6 | 19 | 30 | Biotechnology & Health Technologies 2.4 · Inception |
| 152 | Uganda | Africa | Mixed | −1.1 | 8.8 | 9.9 | 25 | 34 | Biotechnology & Health Technologies 4 · Nascent |
| 154 | Ethiopia | Africa | Mixed | −1.6 | 8.3 | 10.0 | 24 | 34 | Biotechnology & Health Technologies 3.6 · Nascent |
| 155 | Côte d'Ivoire | Africa | Mixed | −1.7 | 8.4 | 10.2 | 19 | 32 | Biotechnology & Health Technologies 2.2 · Inception |
| 156 | Azerbaijan | Russia and Eurasia | Mixed | −2.3 | 14.1 | 16.4 | 25 | 46 | Biotechnology & Health Technologies 2.4 · Inception |
| 157 | Libya | Africa | Mixed | −2.5 | 9.4 | 11.9 | 13 | 21 | Biotechnology & Health Technologies 1.4 · Inception |
| 158 | Mozambique | Africa | Mixed | −3.0 | 8.2 | 11.2 | 17 | 26 | Biotechnology & Health Technologies 2.2 · Inception |
| 159 | Zimbabwe | Africa | Mixed | −3.1 | 7.6 | 10.8 | 19 | 28 | Biotechnology & Health Technologies 2.6 · Inception |
| 160 | Gambia | Africa | Mixed | −3.3 | 8.3 | 11.6 | 14 | 23 | Biotechnology & Health Technologies 1.6 · Inception |
| 161 | Cameroon | Africa | Mixed | −3.5 | 7.6 | 11.2 | 17 | 26 | Biotechnology & Health Technologies 2.2 · Inception |
| 162 | Angola | Africa | Mixed | −3.7 | 7.3 | 11.0 | 14 | 27 | Biotechnology & Health Technologies 1.2 · Inception |
| 163 | Madagascar | Africa | Mixed | −4.0 | 7.4 | 11.4 | 16 | 24 | Biotechnology & Health Technologies 2 · Inception |
| 164 | Mauritania | Africa | Mixed | −4.6 | 7.1 | 11.7 | 12 | 22 | Biotechnology & Health Technologies 1.2 · Inception |
| 165 | Syria | Gulf and Middle East | Mixed | −4.7 | 3.7 | 8.4 | 9 | 16 | Biotechnology & Health Technologies 0.8 · Inception |
| 167 | Malawi | Africa | Mixed | −4.8 | 6.4 | 11.2 | 17 | 26 | Biotechnology & Health Technologies 2.2 · Inception |
| 166 | Benin | Africa | Mixed | −4.8 | 6.0 | 10.8 | 14 | 28 | Biotechnology & Health Technologies 1 · Inception |
| 168 | Lesotho | Africa | Mixed | −5.0 | 6.6 | 11.6 | 12 | 23 | Biotechnology & Health Technologies 0.8 · Inception |
| 169 | Togo | Africa | Mixed | −5.1 | 6.0 | 11.1 | 13 | 26 | Biotechnology & Health Technologies 1 · Inception |
| 170 | Eswatini | Africa | Mixed | −5.2 | 6.2 | 11.3 | 13 | 25 | Biotechnology & Health Technologies 1 · Inception |
| 171 | Djibouti | Africa | Mixed | −5.4 | 6.4 | 11.8 | 9 | 21 | Biotechnology & Health Technologies 0.2 · Inception |
| 173 | Haiti | Latin America and Caribbean | Mixed | −5.7 | 3.1 | 8.8 | 7 | 12 | Biotechnology & Health Technologies 0.6 · Inception |
| 172 | Congo | Africa | Mixed | −5.7 | 6.2 | 11.9 | 11 | 20 | Biotechnology & Health Technologies 0.8 · Inception |
| 174 | Burkina Faso | Africa | Mixed | −5.8 | 5.7 | 11.5 | 14 | 24 | Biotechnology & Health Technologies 1.6 · Inception |
| 175 | Mali | Africa | Mixed | −5.9 | 5.9 | 11.8 | 13 | 21 | Biotechnology & Health Technologies 1.6 · Inception |
| 176 | Uzbekistan | Russia and Eurasia | Mixed | −6.0 | 12.7 | 18.7 | 27 | 38 | Biotechnology & Health Technologies 3.8 · Nascent |
| 177 | Sierra Leone | Africa | Mixed | −6.1 | 5.4 | 11.5 | 13 | 23 | Biotechnology & Health Technologies 1.2 · Inception |
| 178 | Guinea | Africa | Mixed | −6.2 | 5.7 | 12.0 | 12 | 20 | Biotechnology & Health Technologies 1.2 · Inception |
| 179 | DR Congo | Africa | Mixed | −6.4 | 5.9 | 12.3 | 12 | 18 | Biotechnology & Health Technologies 1.6 · Inception |
| 180 | Afghanistan | South Asia | Mixed | −6.5 | 2.0 | 8.5 | 6 | 15 | Biotechnology & Health Technologies 0 · Inception |
| 182 | São Tomé & Príncipe | Africa | Mixed | −6.6 | 5.0 | 11.6 | 10 | 23 | Biotechnology & Health Technologies 0.2 · Inception |
| 181 | Liberia | Africa | Mixed | −6.6 | 5.2 | 11.8 | 11 | 21 | Biotechnology & Health Technologies 0.8 · Inception |
| 183 | Yemen | Gulf and Middle East | Mixed | −6.8 | 2.0 | 8.8 | 5 | 12 | Biotechnology & Health Technologies 0.2 · Inception |
| 184 | Equatorial Guinea | Africa | Mixed | −7.2 | 4.9 | 12.2 | 8 | 19 | Biotechnology & Health Technologies 0.4 · Inception |
| 185 | Niger | Africa | Mixed | −8.5 | 3.5 | 12.0 | 12 | 20 | Biotechnology & Health Technologies 1.2 · Inception |
| 186 | Sudan | Africa | Mixed | −8.7 | 3.9 | 12.6 | 10 | 16 | Biotechnology & Health Technologies 1.2 · Inception |
| 187 | Eritrea | Africa | Mixed | −9.0 | 3.6 | 12.6 | 8 | 16 | Biotechnology & Health Technologies 0.6 · Inception |
| 188 | Burundi | Africa | Mixed | −9.1 | 3.2 | 12.3 | 8 | 18 | Biotechnology & Health Technologies 0.2 · Inception |
| 189 | Comoros | Africa | Mixed | −9.2 | 3.2 | 12.4 | 8 | 17 | Biotechnology & Health Technologies 0.2 · Inception |
| 190 | Guinea-Bissau | Africa | Loser | −10.2 | 2.7 | 12.8 | 6 | 14 | Biotechnology & Health Technologies 0.2 · Inception |
| 191 | Chad | Africa | Loser | −10.6 | 2.2 | 12.8 | 6 | 15 | Biotechnology & Health Technologies 0.2 · Inception |
| 192 | Kyrgyzstan | Russia and Eurasia | Loser | −10.8 | 8.8 | 19.6 | 18 | 35 | Biotechnology & Health Technologies 1.6 · Inception |
| 193 | Central African Rep. | Africa | Loser | −11.1 | 2.2 | 13.3 | 5 | 11 | Biotechnology & Health Technologies 0.2 · Inception |
| 194 | Somalia | Africa | Loser | −11.2 | 2.2 | 13.4 | 4 | 10 | Biotechnology & Health Technologies 0 · Inception |
| 195 | South Sudan | Africa | Loser | −11.3 | 2.1 | 13.4 | 4 | 11 | Biotechnology & Health Technologies 0 · Inception |
| 196 | Tajikistan | Russia and Eurasia | Loser | −15.8 | 5.5 | 21.3 | 15 | 29 | Biotechnology & Health Technologies 1.2 · Inception |
| 197 | Turkmenistan | Russia and Eurasia | Loser | −17.3 | 5.3 | 22.6 | 12 | 25 | Biotechnology & Health Technologies 0.6 · Inception |
Settings of this run
- Required
- Health System CapabilityBiotechnology & Health TechnologiesPopulation HealthNational Resilience & Crisis ManagementInformation Environment & Strategic CommunicationGovernment Effectiveness & Public AdministrationResearch Talent & Knowledge Creation
Readiness is the average of the mean and the minimum of the nation's scores on the capabilities the scenario requires, as a share of the top of the scale. The minimum holds it down: the weakest required capability limits the gain.
- Adaptive
- Health System CapabilityGovernment Effectiveness & Public AdministrationInformation Environment & Strategic Communication
- Gain exposure
- regional exposure (30%); urban share of population (30%); share of population aged 65 and over (ranked) (20%); trade in goods and services relative to gdp (ranked) (20%).
- Loss exposure
- Standing outside the surveillance and manufacturing network: regional exposure (100%). Gain and loss exposure are set nation by nation from indicators where one fits, and by region with named exceptions where none does.
- Likelihood
- 4 per cent over three years and 15 per cent over ten, as used in the opportunity index.